08.04.2016 • News

Monsanto No Longer After Large-Scale Deals

Getting back to business after the collapse of the plan to take over Swiss rival Syngenta, Monsanto’s CEO, Hugh Grant, told journalists this week the company no longer sees “large scale” M&A as a viable strategy.

Instead, he said the company plans to look to research and development, and commercial partnerships to generate growth in its crop protectant and seeds business.

Presenting Monsanto’s quarterly results, Grant said he believes the agrochemicals industry will continue to rationalize, focusing investment to the higher-return options, and this will translate into further R&D or commercial partnerships” for which we are uniquely positioned to participate.”

While the Monsanto chief did not comment on any possible deals that might be in the works, the company has been seen as exploring potential collaborations with BASF and Bayer.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read